***BIG NEWS***
We couldn’t be more delighted with this #RareDiseaseDay announcement of a new Rare Disease Clinical Trial Network, from @hrbireland. And we're very proud to be part of it.
Full press release 👉 bit.ly/3ssuejN
A thread 🧵 (1/6)...
Congratulations to Prof Rachel Crowley (@rachsail) & Prof Cormac McCarthy, of @UCDMedicine, for their drive to make a difference to the rare disease patients that they see in their clinics & people living with rare diseases all across the country. #RareDiseaseDay (2/6)
Kudos to @hrbireland for getting behind their vision and for making such a big commitment to rare diseases, beyond their already significant commitments through the HRCI-HRB Joint Funding Scheme & other schemes. @DonnellyStephen welcomed the announcement. #RareDiseaseDay (3/6)
The Network will support more rare disease clinical trials in Ireland. This means earlier access to new treatments for rare disease patients & better healthcare. It certainly won’t solve all the issues but it’s a really important part of the jigsaw. #RareDiseaseDay (4/6)
We're very proud to be a partner in the network. Our job will be to ensure strong patient involvement. In particular, we'll co-manage a PPI Liasion with UCD, to establish a patient advisory group & to support #PPI throughout the Network. #RareDiseaseDay (5/6)
1/7. So, there is a BIG paper out (not yet peer-reviewed) out looking at the factors associated with #COVID19-related hospital death. Starting with health records of 17 mil UK NHS patients, they studied >5.5K COVID deaths. Graph summarises factors associated with risk of death.
3/7. Interpreting the graph: A 'hazard ratio' of 1 (along dotted red line) has been set by a reference group under each heading e.g. never having smoked. Dots to the right of the red line are indicating higher risk than the reference group and dots to the left, lower risk.
1/8. Much of our hope hangs on immunity. Will people who get #COVID19 be immune afterwards? How long will immunity last? Will we be able to tell who has immunity? Can we use antibodies from immune people as a treatment? Can we make an effective vaccine? #HealthResearchMatters
2/8. While research is at an early phase, it's moving fast. It seems that affected people do develop immunity & that it's likely to last perhaps 1-3 years (rather than months, which would be bad or decades, which would be amazing). It's too early to know the timeframe yet though.
3/8. Immunity means that a vaccine(s) should be possible. If immunity is not long-lasting, prevention might possibly require annual vaccinations, like is the case for flu.
(Side note: we wonder will the anti-vaccination movement wane a little now?).